FDA advisers review gene therapy to treat form of blindness – Washington Post
Philly.com |
FDA advisers review gene therapy to treat form of blindness
Washington Post SILVER SPRING, Md. — U.S. health advisers are reviewing a novel treatment for a rare form of inherited blindness, potentially setting the stage for the launch of a groundbreaking new genetic medicine. The Food and Drug Administration panel will vote … FDA Vote Sets Stage for Gene Therapy’s Future Gene therapy drug developed in Philadelphia helps people with rare hereditary blindness see Experimental gene therapy for blindness considered by FDA |
View original article
Author:
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.